Filter the drugs by their status, phase of research and how they help

COVID-19 is respiratory dissease caused by SARS-CoV-2 virus. Browse the database of drugs treating specific mutations compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Latest database update
Number of references
Actidione Potential treatment - pre-clinical evidence Natural product Antiviral Jul/06/2020 Jul/09/2020 0
Thioflexibilolide A Potential treatment - theoretical effect Natural product Antiviral Jun/25/2020 Jun/29/2020 0
Candidine  Potential treatment - theoretical effect Natural product Antiviral Jun/25/2020 Jun/29/2020 0
Elaidic acid Potential treatment - pre-clinical evidence Natural product Antiviral Jun/16/2020 Jun/22/2020 0
Tauro-ursodeoxycholic acid Potential treatment - pre-clinical evidence Natural product Antiviral Jun/11/2020 Jun/12/2020 0
Glyco-ursodeoxycholic acid Potential treatment - pre-clinical evidence Natural product Antiviral Jun/11/2020 Jun/12/2020 0
Glyco-chenodeoxycholic acid Potential treatment - pre-clinical evidence Natural product Antiviral Jun/11/2020 Jun/12/2020 0
Chenodeoxycholic acid Potential treatment - pre-clinical evidence Natural product Antiviral Jun/11/2020 Jun/12/2020 0
Glycyrrhizin Potential treatment - theoretical effect Natural product Antiviral May/31/2020 Jun/01/2020 0
Lactoferrin Potential treatment - pre-clinical evidence Natural product Antiviral May/27/2020 May/28/2020 0